李富玉教授治疗骨关节炎临床经验研究
|
摘要
本课题分为李富玉教授学术经验总结以及解毒益肾法治疗膝骨性关节炎临床研究两部分。
学术经验总结:从学术思想、临床经验两方面进行阐述。学术思想总结:包括整体恒动、天人相应;调理气化、行滞补虚;疑难重症,从毒论治;衷中参西,病证结合四方面;临床经验总结:通过对病因病机、辨证论治、临床心得的总结,阐明了导师关于肝肾亏虚、瘀毒痹阻是骨痹根本病机的理论观点,系统展现了导师治疗骨痹(骨性关节炎)的临证思路及用药特点。
临床研究:围绕导师临床经验,进行解毒益肾法治疗膝骨性关节炎临床研究。目的:观察中药解毒益肾丸对膝骨性关节炎的疗效及作用机理。方法:自拟活血解毒、补益肝肾的解毒益肾丸与维骨力比较。将辨证为肝肾亏虚、瘀毒痹阻型膝骨性关节炎患者随机分两组治疗,观察组28例,口服解毒益肾丸,对照组29例,口服维骨力胶囊,8周为一疗程,采用国际通用的WOMAC问卷评估、疼痛视觉模拟量表、中医证候量化评价、测定血清MMP-3和TIMP-1含量等指标客观评价解毒益肾丸临床疗效。结果:观察组治疗后能明显降低WOMAC指数、下蹲痛评分、中医症状积分,能降低血清中MMP-3含量,调高TIMP-1含量,但与对照组相比无显著性差异。对中医证侯的改善情况观察组与对照组相比有显著性差异。两组安全性指标无显著性差异。结论:解毒益肾丸和维骨力胶囊均能有效改善膝关节骨关节炎症状,两药疗效相当。但就改善中医证侯而言,解毒益肾丸优于维骨力胶囊。调节血清MMP-3和TIMP-1的水平可能是其发挥疗效的作用机理之一。
The research is devided into two parts: summing-up of Prof. Li Fuyu's clinical experiences in treating knee osteoarthritis and treating osteoarthritis with the method of Detoxificating and Invigorating the Kidney.
Summing-up of Prof. Li Fuyu's clinical experiences: the academic thoughts includes four aspects: correspondence principle of nature and human being, focusing on integrated and lasting motivation; weakness benefiting, being good at geriatric medicine; set forth his views based on toxin, being good at difficulties and vital diseases; stick to traditional Chinese medicine and reference to Western medicine.The clinic experiences: by summing-up the etiology and pathogenesis, differentiation of syndromes and the clinlical thoughts, the author explained the tutor's viewpoint that deficiency of liver and kidney and congestion of toxin and blood is the basic pathogenesis of osteoarthritis, and displayed completed the tutor's clinical thoughtsand drug administering characteristics.
The clinical research: treating osteoarthritis with the method of Detoxificatingand Invigorating the Kidney is based on the clinical experiences of Prof. Li Fuyu. The purpose is to observe the curative effects and the functional mechanism of Detoxificating and Kidney-Invigorating Pill. The method is to compare the Detoxificating and Kidney-Invigorating Pill improving blood circulation and detoxicating, and liver & kidney benefiting with Viartril-S. 60 osteoarthritis patients recognized as deficiency of liver and kidney and congestion of toxin and blood were divided randomly into two groups. The test group took orally Detoxificating and Kidney-Invigorating Pill the control group took Viartril-S Capsule, both for 8 weeks. The therapeutic and security effects were observed through the international WOMAC questionnaire, visual analogue scale (VAS), traditional Chinese medicine symptoms quantitative evaluation, the serum level of MMP-3 and TIMP-1, and so on. The results reveal that in the test group, the treatment shall decrease the WOMAC index, squat pain score and score of Traditional Chinese medicine symptoms evidently, lower the MMP-3 level in serum while increase the TIMP-1 level, with no distinctive differences contrast to the control group; however, there are distinctive differences on the improvement of the Traditional Chinese medicine symptoms between the test group and the control group. There's no distinctive difference between the tow groups in security indexes. The results reveal that both the Detoxificating and Kidney-Invigorating Pill and Viartril-S Capsule can improve the symptoms of osteoarthritis effectively, and two kinds of medicine have equal therapeutic effects. But as far as the improvement of Traditional Chinese medicine symptoms are concerned, the Detoxificating and Kidney-Invigorating Pill is superior to Viartril-S Capsule. The regulation of the serum level of MMP-3 and TIMP-1 may be one of the mechanisms of therapeutic effects.
学术经验总结:从学术思想、临床经验两方面进行阐述。学术思想总结:包括整体恒动、天人相应;调理气化、行滞补虚;疑难重症,从毒论治;衷中参西,病证结合四方面;临床经验总结:通过对病因病机、辨证论治、临床心得的总结,阐明了导师关于肝肾亏虚、瘀毒痹阻是骨痹根本病机的理论观点,系统展现了导师治疗骨痹(骨性关节炎)的临证思路及用药特点。
临床研究:围绕导师临床经验,进行解毒益肾法治疗膝骨性关节炎临床研究。目的:观察中药解毒益肾丸对膝骨性关节炎的疗效及作用机理。方法:自拟活血解毒、补益肝肾的解毒益肾丸与维骨力比较。将辨证为肝肾亏虚、瘀毒痹阻型膝骨性关节炎患者随机分两组治疗,观察组28例,口服解毒益肾丸,对照组29例,口服维骨力胶囊,8周为一疗程,采用国际通用的WOMAC问卷评估、疼痛视觉模拟量表、中医证候量化评价、测定血清MMP-3和TIMP-1含量等指标客观评价解毒益肾丸临床疗效。结果:观察组治疗后能明显降低WOMAC指数、下蹲痛评分、中医症状积分,能降低血清中MMP-3含量,调高TIMP-1含量,但与对照组相比无显著性差异。对中医证侯的改善情况观察组与对照组相比有显著性差异。两组安全性指标无显著性差异。结论:解毒益肾丸和维骨力胶囊均能有效改善膝关节骨关节炎症状,两药疗效相当。但就改善中医证侯而言,解毒益肾丸优于维骨力胶囊。调节血清MMP-3和TIMP-1的水平可能是其发挥疗效的作用机理之一。
The research is devided into two parts: summing-up of Prof. Li Fuyu's clinical experiences in treating knee osteoarthritis and treating osteoarthritis with the method of Detoxificating and Invigorating the Kidney.
Summing-up of Prof. Li Fuyu's clinical experiences: the academic thoughts includes four aspects: correspondence principle of nature and human being, focusing on integrated and lasting motivation; weakness benefiting, being good at geriatric medicine; set forth his views based on toxin, being good at difficulties and vital diseases; stick to traditional Chinese medicine and reference to Western medicine.The clinic experiences: by summing-up the etiology and pathogenesis, differentiation of syndromes and the clinlical thoughts, the author explained the tutor's viewpoint that deficiency of liver and kidney and congestion of toxin and blood is the basic pathogenesis of osteoarthritis, and displayed completed the tutor's clinical thoughtsand drug administering characteristics.
The clinical research: treating osteoarthritis with the method of Detoxificatingand Invigorating the Kidney is based on the clinical experiences of Prof. Li Fuyu. The purpose is to observe the curative effects and the functional mechanism of Detoxificating and Kidney-Invigorating Pill. The method is to compare the Detoxificating and Kidney-Invigorating Pill improving blood circulation and detoxicating, and liver & kidney benefiting with Viartril-S. 60 osteoarthritis patients recognized as deficiency of liver and kidney and congestion of toxin and blood were divided randomly into two groups. The test group took orally Detoxificating and Kidney-Invigorating Pill the control group took Viartril-S Capsule, both for 8 weeks. The therapeutic and security effects were observed through the international WOMAC questionnaire, visual analogue scale (VAS), traditional Chinese medicine symptoms quantitative evaluation, the serum level of MMP-3 and TIMP-1, and so on. The results reveal that in the test group, the treatment shall decrease the WOMAC index, squat pain score and score of Traditional Chinese medicine symptoms evidently, lower the MMP-3 level in serum while increase the TIMP-1 level, with no distinctive differences contrast to the control group; however, there are distinctive differences on the improvement of the Traditional Chinese medicine symptoms between the test group and the control group. There's no distinctive difference between the tow groups in security indexes. The results reveal that both the Detoxificating and Kidney-Invigorating Pill and Viartril-S Capsule can improve the symptoms of osteoarthritis effectively, and two kinds of medicine have equal therapeutic effects. But as far as the improvement of Traditional Chinese medicine symptoms are concerned, the Detoxificating and Kidney-Invigorating Pill is superior to Viartril-S Capsule. The regulation of the serum level of MMP-3 and TIMP-1 may be one of the mechanisms of therapeutic effects.
引文
[1]姜良铎,张文生.从毒论治初探.北京中医药大学学报.1998,21(5):2-3.
[2]王永炎.关于提高脑血管疾病疗效难点的思考.中国中西医结合杂志.1997,17(4):195-196.
[3]于俊生.毒邪学说与临床,北京:中国中医药出版社.2000,第1版:85-86.
[4]戴慎,薛建国,岳沛平.中医病证诊疗标准与方剂选用,北京:人民卫生出版社.2001,第1版:243-246.
[5]黄俊卿.论《诸病源候论》的痹病理论体系.河南中医药学刊.1997,(6):2.
[6]肖林蓉,郑红.明清医家论治骨痹(骨关节炎)临床理论的发展.中医文献杂志.2003,(2):10.
[7]孙刚,王永锡.骨内静脉瘀滞、骨内高压在骨性关节炎发病中的作用初探.中华骨科杂志.1991,11(5):374.
[8]Reginster JY.The prevalence and burden of arthritis Rheumatology.2002,41(suppl 1):3-6.
[9]曾庆馀.症状性OA临床和流行病学探讨.中华内科学杂志.1995,34(2):88.
[10]Long L,Soeken k,Ernst E.Herbal medicines for the treatment ofosteoarthritis:a systematic review.J Rheumafology.2001,40:779-793.
[11]Aktnab Rm Asch E,Bloch G,et al.Development of criteria for the classification and reporting of osteoarthritis:classification of osteoarthritis of the knee.Arthritis Rheum.1986,29:1039-1049.
[12]Kellgren JH,Lawrence JS.Radiological assessment of osteoarthrosis.Ann Rheum Dis.1957,16:494-502.
[13]郑筱萸主编.中药新药临床研究指导原则(试行),北京:中国医药科技出版社.2005:353.
[14]Roos EM,Klassbo M,Lohmander LS.WOMAC osteoarthritis index.Reliability.validity,and responsiveness in patients with arthroscopically assessed osteoarthritis.Westem Ontario and MacMaster Universities.Scand J Rheumatol.1999,28(4):210-215.
[15]Bonica JJ.The management of pain.2nd ed Philadelphia.Lea and Febiger,1990:581.
[16]Creemers L,Jansen I,Docherty A,et al.Gelatinase A(MMP-2)and cysteine proteinases are essential for the degradation of collagen in soft connective tissue.Matrix Biol,1998,17:35-46.
[17]Martel-Pelletier J,McCollumR,Fujimoto N,et al.Excess ofmetalloProteases Over tissue inhibitor of metal oproteases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.Lab invest.1994,70:807-815.
[18]Naito K,Takahashi M,Kuahida K,et al.Rheumatology(Oxford).1999,38(6):510-515.
[19]Manicourt D,Fujimoto N,Obata K,et al.Serum levels of collagenase,stromelysin-1,and TIMP-1:Age-and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis.Arthritis Rheum.1994,37:1774-1783.
[20]河北新医大学药物治疗学研究室及放射医学研究室.徐长卿的实验研究.新医药杂志.1973,(10):30.
[21]吉中强.11种中药对大鼠血小板聚集和红细胞流变性的影响.山东中医志.2000,9(2):107.
[22]陆兔林.牛膝不同炮制品镇痛抗炎作用研究.中药材.1997,20(10):5-7.
[23]邹丹,全宏勋,胡群员.牛膝精对辐射小鼠造血干细胞增殖与分化的影响.四川中医.2003,21(7):16-17.
[24]高晓燕,王大为,李发美,等.牛膝提取物对成骨样细胞增殖的作用.沈阳药科大学学报.2000,17(3):211-213.
[25]孙奋勇,潘秋辉,洪岸.牛膝促进成骨细胞增殖的作用与机理研究.中药材,2004;27(4):264-266.
[26]王浴生主编.中药药理与应用,北京:人民卫生出版社.1983,第1版:483.
[27]王大为.杜仲对成骨样细胞增殖的影响.中药药理与临床.2000,16(4):24.
[28]周春凤,莱萌,王秀华等.土鳖虫对大鼠血液流变学的影响.中草药.1994, 25(1):29.
[29]王怡.动物类活血化瘀药对血流变性作用的比较研究.中药药理与临床.1997,13(3):1.
[30]黄金保,冯改壮,刘骁驷等.土鳖虫抗兔心脑缺氧实验研究.长治医学院学报.1994,(2):102.
[31]王本祥主编.现代中药药理与临床,天津:天津科技翻译出版公司.2004,第1版:112.
[32]王本祥主编.现代中药药理学.天津:天津科学技术出版社.1997,第1版:898.
[33]粟坤.川芎嗪对老龄大鼠脑、心、肝脏过氧化脂质含量的影响.佳木斯医学院学报.1997,20(1):11.
[34]江苏新医学院编.中药大词典(下册),上海:上海科技出版社.1986:2032-2033.
[35]孙刚,王永惕.骨内静脉瘀滞、骨内高压在骨关节炎中的作用初探(家兔膝关节研究).中华骨科杂志.1991,11(5):374-376.
[36]Yuan GH,Masuko-hougo k,kato T,et al.Immunological intervention in the Pathogenesis of Osteoarthritis.Asthritis Rheum.2003,48(3):602-611.
[1]陈灏珠.实用内科学.北京:人民卫生出版社,2001.2356-2359.
[2]张乃峥.临床风湿病学.上海:上海科技出版社,1997.349-359.
[3]许建荣,柴维敏.膝类风湿性关节炎和骨关节炎的MRI表现特点和比较骨骼肌肉放射学.临床放射学杂志,2001,20(11):862-864.
[4]高益民.膝关节骨关节炎Ⅱ期临床试验方案.中药新药与临床药理,1998,9(1):16.
[5]李平,韩明向,孔秀媞.肾虚络阻是骨关节炎的病机特点.中医药临床杂志,2006,18(1):89-90.
[6]贺宪,魏春山.膝骨性关节炎的病机和防治机制探讨.山东中医杂志,2005,24(2):73-75.
[7]徐传毅,樊越光,宁显明.肾虚血瘀与膝关节骨关节炎关系初探.新中医,2002,34(3):7-8.
[8]陈龙全,郝双阶.复方竹节参片配合穴位注射治疗膝骨性关节炎82例.陕西中医,2004,25(8):716-717.
[9]杨挺,王培民,诸方受,等.膝宁方治疗肾阳虚寒湿证膝骨关节炎患者的康复评定.辽宁中医杂志,2007,34(3):294-295.
[10]周斌,樊粤光,曾意荣,等.中药关节康治疗膝骨关节炎临床研究.广州中医药大学学报,2006,23(6):476-479.
[11]邬亚军,赵治友.中药治疗膝关节骨关节炎的临床观察.四川中医,2006,24(6):80-81.
[12]谢国平,樊粤光,王海彬.补肝肾方治疗膝关节骨性关节炎的生存质量评价.中医药导报,2005,11(9):24-26.
[13]曹月龙,郑昱新,石印玉,等.养血软坚胶囊治疗膝骨关节炎疗效及安全性评价的随机对照试验.中国药物与临床,2004,4(6):423-427.
[14]王世彪,郁俊文,张建军,等.骨痹威灵丸治疗骨性关节炎临床研究.中国中医骨伤科杂志,2004,12(3):41-42.
[15]发刘继华,张快强.通痹丸治疗膝骨关节炎90例.陕西中医,2005,26(3):219-220.
[16]王少伟,李伟居,黄桂忠,等冲药熏洗配合手法按摩治疗膝关节骨性关节炎100例疗效观察.新中医,2007,39(1):28-29.
[17]顾凯平,张飞飞.中药熏蒸治疗膝骨关节炎临床疗效观察.江西中医药,2003,34(12):252.
[18]刘金文,冯立科,许少健.金桂外洗方对膝骨关节炎患者生存质量的改善作用.中医药临床杂志,2004,16(1):47.
[19]葛鸿庆,陈文治,余宇峰,等.腹针治疗膝关节骨性关节炎患者生存质量的影响.新中医,2007,39(2):41-42.
[20]付勇,康明非,陈日新,等.无痛化脓灸治疗膝关节骨性关节炎疗效观察.中国针灸,2007,27(7):513-515.
[21]裘敏蕾,戴琪萍,车涛等.电针膝眼穴治疗膝骨性关节炎的临床研究.中医正骨,2006,18(3):15-16.
[22]李常度,黄倍勇,杨旭光,等.温针灸治疗虚寒型膝骨关节炎疗效观察.中国针灸,2006,26(3):189-191.
[23]刘立安,马春燕.温针灸治疗老年性膝骨关节病的临床观察.中国针灸,2003,23(10):579-580.
[24]蒋生云.推拿治疗膝关节骨关节炎50例体会.按摩与导引,2003,19(1):36-37.
[25]杨宏.按摩治疗膝关节骨关节病.中医骨伤,2002,15(8):461.
[26]张吴,杜宁,任峰等.手法治疗实验性膝骨关节炎扫描电镜研究.中国中医骨伤科杂志,2000,8(2):1-3.
[27]滕蔚然,杜宁,史炜镔.手法治疗实验性膝骨关节炎扫描电镜观察.中国中医骨伤科杂志,2000,8(5):46.
[28]陈利新,马少云,莫卫海.中药离子导入治疗膝关节骨性关节炎400例临床报告.医学理论与实践,2003;16(5):557-558.
[29]刁维珍,毕鸿雁,伊长松.中药离子导入治疗退行性膝骨关节炎1000例疗效分析.山东中医药大学学报,2003;27(3):199-200.
[30]颜玉莲,熊桂仙,王宗春,等二乌离子导入液治疗膝关节骨性关节炎疗效观察.中国药师,2000;3(3): 179-180.
[31]郑昱新,詹红生,张玉虎,等.奇正青鹏膏剂治疗膝骨关节炎的随机对照临床研究.中国骨伤,2006,19(5):316-317.
[32]高翔,吴弢,腾松茂,等.华伤膝Ⅰ号熨疗治疗膝骨关节病103例.中医外治杂志,2001,10(5):6-7.
[33]查振刚,宋炎成,赵明杰,等.丹参和透明质酸钠恢复膝关节功能的对比.中国临床康复,2002;6(24):3746-3747.
[34]雷明,陈红明.综合疗法治疗膝关节骨性关节炎46例.新中医,2005,37(6):71-72.
[35]许学猛.中药内外兼治治疗退行性膝关节病的临床研究.中国中医骨伤科杂志,2000,8(6):21-24.
[36]孔熙春 腾药梅花针组合治疗膝骨关节炎50例临床报道中国中医骨伤科杂志,2002,10(4):37.
[37]杨向炎.手法及中药为主综合治疗膝关节骨关节炎.浙江中西医结合杂志,2004,14(2):116-117.
[38]接力刚,黄清春,沈鹰,等.复方丹参改善骨性关节炎患者关节功能58例.中国临床康复,2003;7(29):4024.
[39]韩村显,宁静,张小卫,等.中药离子导入并玻璃酸钠治疗膝骨关节炎80例.陕西中医,2006,27(11):1363-1364.
[40]李卫宁,刘向前,卢敏等.复方温通散外敷加关节腔内注射透明质酸钠治疗膝关节骨关节炎临床观察.湖南中医学院学报,2004,24(1):50-51.
[41]王睿,孔晓海.中西医结合治疗膝关节骨性关节炎129例疗效观察.现代中西医结合杂志,2004;13(14):1825.
[1]M Rossignol,A Leclerc,P Hilliquin,et al.Primary osteoarthritis and occupations:A national cross sectional survey of 10412 symptomatic patients.Occupations and Environmental medicine.London,2003,60(11):882.
[2]刘向前,姚共和,杨少锋,等.624例膝关节骨关节炎流行病学分析.湖南中医学院学报.2005,25(5):57-60.
[3]许鹏,姚建锋,蔡乾坤,等.骨关节病患者病情程度与体内自由基含量变化分析的影响.中国矫形外科杂志.2001,8(5):469.
[4]Kujala UM,Kettunen J,Paananen H,et al.Knee osteoarthritis in former runners,soccer players,weight lifters and shooters.Arthritis Rheum.1995,38:539-546.
[5]C Emery M,Fondow D,Stainbrook,et al.Effcts of relaxation on pain response older men and women with osteoarthritis.The Gerontologist Washington.2004,44(1):352.
[6]邱贵兴.骨关节炎流行病学和病因学新进展.继续医学教育.2005,7:68-69.
[7]Radin EL.Mechanical aspects of osteoarthritis.Bull Rheum Dis.1976,26(7):862-865.
[8]Dequeker J,Boonen S,Aerssens J,et al.Inverse relationship osteoarthritis-osteoporosis:what is the evidence? What are the consequences? Br J Rheumatol.1996,35(9):813-818.
[9]Majima T,Marchuk LL,Shrive NG,et al.In-vitro cyclic tensile loading of an immobilized and mobilized ligament auto graft selectively inhibits mRNA levels for collagenase(MMP-1).J Orthop Sci.2000,5:503-510.
[10]Creemers L,Jansen I,Docherty A,et al.Gelatinase A(MMP-2)and cysteine proteinases are essential for the degradation of collagen in soft connective tissue.Matrix Biol.1998,17:35-46.
[11]Wei XQ,Wright GC,Sokoloff L.The effects of sodium selentte on chondrcytesin monolayer culture.Arthritis Rheum.1986,29:660.
[12]Martel-Pelletier J,McCollumR,Fujimoto N,et al.Excess of metalloProteases over tissue inhibitor of metal oproteases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.Lab invest.1994,70:807-815.
[13]Ellerbroek SM,Wu YI,Overall CM,et al.Functional interplay between type Ⅰ collagen and cell surface matrix metalloproteinase activity.J Biol Chem.2001,276:24833-24842.
[14]Martignetti J,Al Aqeel A,Al Sewairi W,et al.Mutation of the matrix metalloproteinase 2gene(MMP2)causes a multicentric osteolysis and arthritis syndrome.Nat Genet.2001,28:261-265.
[15]Takagi M,Santavirta S,Ida H,et al.Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints.Clin Orthop.1998,352:34-45.
[16]Nagase H.Stromelysins 1 and 2.In Parks W,Mecham R(eds).Matrix Metalloproteinases.San Diego,Academic Press.1998:43-84.
[17]Takagi M,Santavirta S,Ida H,et al.Matrix metal oproteinases and tissue inhibitors of metalloproteinasea in loose artificial hip joints.Clin Orthop.1998,352:34-45.
[18]郑毅,陆江阳,孙笑非等.骨性关节炎患者滑膜和关节软骨中金属蛋白酶组织抑制物-1的研究.天津医药.2001,29(09):529-531.
[19]Naito K,Takahashi M,Kuahida K,et al.Rheumatology(Oxford).1999;38(6):510-515.
[20]CC Anroldi,JC Djurhnns,J Heerfordt et al.Intraosseous phlebograpny Intraosseous Pressure measurement and Tc-polyphosphate scintigraphy in patient with various painful conditional in the hip and knee.Acta orthop scand Feb.1980:51(1):19-28.
[21]张毓洲,许露玫,许振华,等.正常与骨内高压下骨髓微循环冷冻割断扫描电镜观察.中华骨科杂志.1999,5:13.
[22]刘晓平,于秀淳,沈志鹏,等.膝关节骨性关节炎胫骨上端骨内血管造影.临床放射学杂志.1994,13(2):106.
[23]郑召民,许振华.骨内高压与活血化瘀.中国中医骨伤科杂志.1994,2(3):43.
[24]莫简.医用氧自由基生物学导论.北京:人民卫生出版社.1989:93-99.
[25]张法浩,许善锦,王夔.自由基在大骨节病病理过程中的作用.北京医科大学学报.1990,22:59.
[26]孙材江,王慧,杨锡兰,等.退行性膝关节炎患者氧自由基代谢的观察.中华骨科杂志.1992,12:433.
[27]邵洪.氧自由基与蛋白质代谢.国外医学分子生物学分册.1990,12:42-44.
[28]彭丹,孙材江,周江南.一氧化氨在实验性骨关节炎软骨细胞凋亡中的作用.中华风湿病学杂志.2000,(4):232-234.
[29]Yuan GH,Masuko-Hongo K,Kato T,et al.Immunological intervention in the Pathogenesis of Osteoarthritis.Arthritis Rheum.2003,48(3):602-611.
[30]Alsalameh S,Jahn B,Krause A,et al.Antigenicity and accessory cell function of human articular chondrocytes.J Rheumatol.1991,18(3):414-421.
[31]毕五蝉,王亦驰.膝关节载荷传导紊乱所致关节炎关节软骨退变.中华骨科杂志.1991,11(4):303.
[32]郑清波,施祀.蛋白酶在骨关节炎软骨退变中的作用.中医正骨.1995,7(4):3.
[2]王永炎.关于提高脑血管疾病疗效难点的思考.中国中西医结合杂志.1997,17(4):195-196.
[3]于俊生.毒邪学说与临床,北京:中国中医药出版社.2000,第1版:85-86.
[4]戴慎,薛建国,岳沛平.中医病证诊疗标准与方剂选用,北京:人民卫生出版社.2001,第1版:243-246.
[5]黄俊卿.论《诸病源候论》的痹病理论体系.河南中医药学刊.1997,(6):2.
[6]肖林蓉,郑红.明清医家论治骨痹(骨关节炎)临床理论的发展.中医文献杂志.2003,(2):10.
[7]孙刚,王永锡.骨内静脉瘀滞、骨内高压在骨性关节炎发病中的作用初探.中华骨科杂志.1991,11(5):374.
[8]Reginster JY.The prevalence and burden of arthritis Rheumatology.2002,41(suppl 1):3-6.
[9]曾庆馀.症状性OA临床和流行病学探讨.中华内科学杂志.1995,34(2):88.
[10]Long L,Soeken k,Ernst E.Herbal medicines for the treatment ofosteoarthritis:a systematic review.J Rheumafology.2001,40:779-793.
[11]Aktnab Rm Asch E,Bloch G,et al.Development of criteria for the classification and reporting of osteoarthritis:classification of osteoarthritis of the knee.Arthritis Rheum.1986,29:1039-1049.
[12]Kellgren JH,Lawrence JS.Radiological assessment of osteoarthrosis.Ann Rheum Dis.1957,16:494-502.
[13]郑筱萸主编.中药新药临床研究指导原则(试行),北京:中国医药科技出版社.2005:353.
[14]Roos EM,Klassbo M,Lohmander LS.WOMAC osteoarthritis index.Reliability.validity,and responsiveness in patients with arthroscopically assessed osteoarthritis.Westem Ontario and MacMaster Universities.Scand J Rheumatol.1999,28(4):210-215.
[15]Bonica JJ.The management of pain.2nd ed Philadelphia.Lea and Febiger,1990:581.
[16]Creemers L,Jansen I,Docherty A,et al.Gelatinase A(MMP-2)and cysteine proteinases are essential for the degradation of collagen in soft connective tissue.Matrix Biol,1998,17:35-46.
[17]Martel-Pelletier J,McCollumR,Fujimoto N,et al.Excess ofmetalloProteases Over tissue inhibitor of metal oproteases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.Lab invest.1994,70:807-815.
[18]Naito K,Takahashi M,Kuahida K,et al.Rheumatology(Oxford).1999,38(6):510-515.
[19]Manicourt D,Fujimoto N,Obata K,et al.Serum levels of collagenase,stromelysin-1,and TIMP-1:Age-and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis.Arthritis Rheum.1994,37:1774-1783.
[20]河北新医大学药物治疗学研究室及放射医学研究室.徐长卿的实验研究.新医药杂志.1973,(10):30.
[21]吉中强.11种中药对大鼠血小板聚集和红细胞流变性的影响.山东中医志.2000,9(2):107.
[22]陆兔林.牛膝不同炮制品镇痛抗炎作用研究.中药材.1997,20(10):5-7.
[23]邹丹,全宏勋,胡群员.牛膝精对辐射小鼠造血干细胞增殖与分化的影响.四川中医.2003,21(7):16-17.
[24]高晓燕,王大为,李发美,等.牛膝提取物对成骨样细胞增殖的作用.沈阳药科大学学报.2000,17(3):211-213.
[25]孙奋勇,潘秋辉,洪岸.牛膝促进成骨细胞增殖的作用与机理研究.中药材,2004;27(4):264-266.
[26]王浴生主编.中药药理与应用,北京:人民卫生出版社.1983,第1版:483.
[27]王大为.杜仲对成骨样细胞增殖的影响.中药药理与临床.2000,16(4):24.
[28]周春凤,莱萌,王秀华等.土鳖虫对大鼠血液流变学的影响.中草药.1994, 25(1):29.
[29]王怡.动物类活血化瘀药对血流变性作用的比较研究.中药药理与临床.1997,13(3):1.
[30]黄金保,冯改壮,刘骁驷等.土鳖虫抗兔心脑缺氧实验研究.长治医学院学报.1994,(2):102.
[31]王本祥主编.现代中药药理与临床,天津:天津科技翻译出版公司.2004,第1版:112.
[32]王本祥主编.现代中药药理学.天津:天津科学技术出版社.1997,第1版:898.
[33]粟坤.川芎嗪对老龄大鼠脑、心、肝脏过氧化脂质含量的影响.佳木斯医学院学报.1997,20(1):11.
[34]江苏新医学院编.中药大词典(下册),上海:上海科技出版社.1986:2032-2033.
[35]孙刚,王永惕.骨内静脉瘀滞、骨内高压在骨关节炎中的作用初探(家兔膝关节研究).中华骨科杂志.1991,11(5):374-376.
[36]Yuan GH,Masuko-hougo k,kato T,et al.Immunological intervention in the Pathogenesis of Osteoarthritis.Asthritis Rheum.2003,48(3):602-611.
[1]陈灏珠.实用内科学.北京:人民卫生出版社,2001.2356-2359.
[2]张乃峥.临床风湿病学.上海:上海科技出版社,1997.349-359.
[3]许建荣,柴维敏.膝类风湿性关节炎和骨关节炎的MRI表现特点和比较骨骼肌肉放射学.临床放射学杂志,2001,20(11):862-864.
[4]高益民.膝关节骨关节炎Ⅱ期临床试验方案.中药新药与临床药理,1998,9(1):16.
[5]李平,韩明向,孔秀媞.肾虚络阻是骨关节炎的病机特点.中医药临床杂志,2006,18(1):89-90.
[6]贺宪,魏春山.膝骨性关节炎的病机和防治机制探讨.山东中医杂志,2005,24(2):73-75.
[7]徐传毅,樊越光,宁显明.肾虚血瘀与膝关节骨关节炎关系初探.新中医,2002,34(3):7-8.
[8]陈龙全,郝双阶.复方竹节参片配合穴位注射治疗膝骨性关节炎82例.陕西中医,2004,25(8):716-717.
[9]杨挺,王培民,诸方受,等.膝宁方治疗肾阳虚寒湿证膝骨关节炎患者的康复评定.辽宁中医杂志,2007,34(3):294-295.
[10]周斌,樊粤光,曾意荣,等.中药关节康治疗膝骨关节炎临床研究.广州中医药大学学报,2006,23(6):476-479.
[11]邬亚军,赵治友.中药治疗膝关节骨关节炎的临床观察.四川中医,2006,24(6):80-81.
[12]谢国平,樊粤光,王海彬.补肝肾方治疗膝关节骨性关节炎的生存质量评价.中医药导报,2005,11(9):24-26.
[13]曹月龙,郑昱新,石印玉,等.养血软坚胶囊治疗膝骨关节炎疗效及安全性评价的随机对照试验.中国药物与临床,2004,4(6):423-427.
[14]王世彪,郁俊文,张建军,等.骨痹威灵丸治疗骨性关节炎临床研究.中国中医骨伤科杂志,2004,12(3):41-42.
[15]发刘继华,张快强.通痹丸治疗膝骨关节炎90例.陕西中医,2005,26(3):219-220.
[16]王少伟,李伟居,黄桂忠,等冲药熏洗配合手法按摩治疗膝关节骨性关节炎100例疗效观察.新中医,2007,39(1):28-29.
[17]顾凯平,张飞飞.中药熏蒸治疗膝骨关节炎临床疗效观察.江西中医药,2003,34(12):252.
[18]刘金文,冯立科,许少健.金桂外洗方对膝骨关节炎患者生存质量的改善作用.中医药临床杂志,2004,16(1):47.
[19]葛鸿庆,陈文治,余宇峰,等.腹针治疗膝关节骨性关节炎患者生存质量的影响.新中医,2007,39(2):41-42.
[20]付勇,康明非,陈日新,等.无痛化脓灸治疗膝关节骨性关节炎疗效观察.中国针灸,2007,27(7):513-515.
[21]裘敏蕾,戴琪萍,车涛等.电针膝眼穴治疗膝骨性关节炎的临床研究.中医正骨,2006,18(3):15-16.
[22]李常度,黄倍勇,杨旭光,等.温针灸治疗虚寒型膝骨关节炎疗效观察.中国针灸,2006,26(3):189-191.
[23]刘立安,马春燕.温针灸治疗老年性膝骨关节病的临床观察.中国针灸,2003,23(10):579-580.
[24]蒋生云.推拿治疗膝关节骨关节炎50例体会.按摩与导引,2003,19(1):36-37.
[25]杨宏.按摩治疗膝关节骨关节病.中医骨伤,2002,15(8):461.
[26]张吴,杜宁,任峰等.手法治疗实验性膝骨关节炎扫描电镜研究.中国中医骨伤科杂志,2000,8(2):1-3.
[27]滕蔚然,杜宁,史炜镔.手法治疗实验性膝骨关节炎扫描电镜观察.中国中医骨伤科杂志,2000,8(5):46.
[28]陈利新,马少云,莫卫海.中药离子导入治疗膝关节骨性关节炎400例临床报告.医学理论与实践,2003;16(5):557-558.
[29]刁维珍,毕鸿雁,伊长松.中药离子导入治疗退行性膝骨关节炎1000例疗效分析.山东中医药大学学报,2003;27(3):199-200.
[30]颜玉莲,熊桂仙,王宗春,等二乌离子导入液治疗膝关节骨性关节炎疗效观察.中国药师,2000;3(3): 179-180.
[31]郑昱新,詹红生,张玉虎,等.奇正青鹏膏剂治疗膝骨关节炎的随机对照临床研究.中国骨伤,2006,19(5):316-317.
[32]高翔,吴弢,腾松茂,等.华伤膝Ⅰ号熨疗治疗膝骨关节病103例.中医外治杂志,2001,10(5):6-7.
[33]查振刚,宋炎成,赵明杰,等.丹参和透明质酸钠恢复膝关节功能的对比.中国临床康复,2002;6(24):3746-3747.
[34]雷明,陈红明.综合疗法治疗膝关节骨性关节炎46例.新中医,2005,37(6):71-72.
[35]许学猛.中药内外兼治治疗退行性膝关节病的临床研究.中国中医骨伤科杂志,2000,8(6):21-24.
[36]孔熙春 腾药梅花针组合治疗膝骨关节炎50例临床报道中国中医骨伤科杂志,2002,10(4):37.
[37]杨向炎.手法及中药为主综合治疗膝关节骨关节炎.浙江中西医结合杂志,2004,14(2):116-117.
[38]接力刚,黄清春,沈鹰,等.复方丹参改善骨性关节炎患者关节功能58例.中国临床康复,2003;7(29):4024.
[39]韩村显,宁静,张小卫,等.中药离子导入并玻璃酸钠治疗膝骨关节炎80例.陕西中医,2006,27(11):1363-1364.
[40]李卫宁,刘向前,卢敏等.复方温通散外敷加关节腔内注射透明质酸钠治疗膝关节骨关节炎临床观察.湖南中医学院学报,2004,24(1):50-51.
[41]王睿,孔晓海.中西医结合治疗膝关节骨性关节炎129例疗效观察.现代中西医结合杂志,2004;13(14):1825.
[1]M Rossignol,A Leclerc,P Hilliquin,et al.Primary osteoarthritis and occupations:A national cross sectional survey of 10412 symptomatic patients.Occupations and Environmental medicine.London,2003,60(11):882.
[2]刘向前,姚共和,杨少锋,等.624例膝关节骨关节炎流行病学分析.湖南中医学院学报.2005,25(5):57-60.
[3]许鹏,姚建锋,蔡乾坤,等.骨关节病患者病情程度与体内自由基含量变化分析的影响.中国矫形外科杂志.2001,8(5):469.
[4]Kujala UM,Kettunen J,Paananen H,et al.Knee osteoarthritis in former runners,soccer players,weight lifters and shooters.Arthritis Rheum.1995,38:539-546.
[5]C Emery M,Fondow D,Stainbrook,et al.Effcts of relaxation on pain response older men and women with osteoarthritis.The Gerontologist Washington.2004,44(1):352.
[6]邱贵兴.骨关节炎流行病学和病因学新进展.继续医学教育.2005,7:68-69.
[7]Radin EL.Mechanical aspects of osteoarthritis.Bull Rheum Dis.1976,26(7):862-865.
[8]Dequeker J,Boonen S,Aerssens J,et al.Inverse relationship osteoarthritis-osteoporosis:what is the evidence? What are the consequences? Br J Rheumatol.1996,35(9):813-818.
[9]Majima T,Marchuk LL,Shrive NG,et al.In-vitro cyclic tensile loading of an immobilized and mobilized ligament auto graft selectively inhibits mRNA levels for collagenase(MMP-1).J Orthop Sci.2000,5:503-510.
[10]Creemers L,Jansen I,Docherty A,et al.Gelatinase A(MMP-2)and cysteine proteinases are essential for the degradation of collagen in soft connective tissue.Matrix Biol.1998,17:35-46.
[11]Wei XQ,Wright GC,Sokoloff L.The effects of sodium selentte on chondrcytesin monolayer culture.Arthritis Rheum.1986,29:660.
[12]Martel-Pelletier J,McCollumR,Fujimoto N,et al.Excess of metalloProteases over tissue inhibitor of metal oproteases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.Lab invest.1994,70:807-815.
[13]Ellerbroek SM,Wu YI,Overall CM,et al.Functional interplay between type Ⅰ collagen and cell surface matrix metalloproteinase activity.J Biol Chem.2001,276:24833-24842.
[14]Martignetti J,Al Aqeel A,Al Sewairi W,et al.Mutation of the matrix metalloproteinase 2gene(MMP2)causes a multicentric osteolysis and arthritis syndrome.Nat Genet.2001,28:261-265.
[15]Takagi M,Santavirta S,Ida H,et al.Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints.Clin Orthop.1998,352:34-45.
[16]Nagase H.Stromelysins 1 and 2.In Parks W,Mecham R(eds).Matrix Metalloproteinases.San Diego,Academic Press.1998:43-84.
[17]Takagi M,Santavirta S,Ida H,et al.Matrix metal oproteinases and tissue inhibitors of metalloproteinasea in loose artificial hip joints.Clin Orthop.1998,352:34-45.
[18]郑毅,陆江阳,孙笑非等.骨性关节炎患者滑膜和关节软骨中金属蛋白酶组织抑制物-1的研究.天津医药.2001,29(09):529-531.
[19]Naito K,Takahashi M,Kuahida K,et al.Rheumatology(Oxford).1999;38(6):510-515.
[20]CC Anroldi,JC Djurhnns,J Heerfordt et al.Intraosseous phlebograpny Intraosseous Pressure measurement and Tc-polyphosphate scintigraphy in patient with various painful conditional in the hip and knee.Acta orthop scand Feb.1980:51(1):19-28.
[21]张毓洲,许露玫,许振华,等.正常与骨内高压下骨髓微循环冷冻割断扫描电镜观察.中华骨科杂志.1999,5:13.
[22]刘晓平,于秀淳,沈志鹏,等.膝关节骨性关节炎胫骨上端骨内血管造影.临床放射学杂志.1994,13(2):106.
[23]郑召民,许振华.骨内高压与活血化瘀.中国中医骨伤科杂志.1994,2(3):43.
[24]莫简.医用氧自由基生物学导论.北京:人民卫生出版社.1989:93-99.
[25]张法浩,许善锦,王夔.自由基在大骨节病病理过程中的作用.北京医科大学学报.1990,22:59.
[26]孙材江,王慧,杨锡兰,等.退行性膝关节炎患者氧自由基代谢的观察.中华骨科杂志.1992,12:433.
[27]邵洪.氧自由基与蛋白质代谢.国外医学分子生物学分册.1990,12:42-44.
[28]彭丹,孙材江,周江南.一氧化氨在实验性骨关节炎软骨细胞凋亡中的作用.中华风湿病学杂志.2000,(4):232-234.
[29]Yuan GH,Masuko-Hongo K,Kato T,et al.Immunological intervention in the Pathogenesis of Osteoarthritis.Arthritis Rheum.2003,48(3):602-611.
[30]Alsalameh S,Jahn B,Krause A,et al.Antigenicity and accessory cell function of human articular chondrocytes.J Rheumatol.1991,18(3):414-421.
[31]毕五蝉,王亦驰.膝关节载荷传导紊乱所致关节炎关节软骨退变.中华骨科杂志.1991,11(4):303.
[32]郑清波,施祀.蛋白酶在骨关节炎软骨退变中的作用.中医正骨.1995,7(4):3.